0001114220-18-000080.txt : 20180712 0001114220-18-000080.hdr.sgml : 20180712 20180712180211 ACCESSION NUMBER: 0001114220-18-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180630 FILED AS OF DATE: 20180712 DATE AS OF CHANGE: 20180712 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cameron Kevin J CENTRAL INDEX KEY: 0001398422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 18951315 MAIL ADDRESS: STREET 1: C/O KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 4 1 wf-form4_153143290994415.xml FORM 4 X0306 4 2018-06-30 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001398422 Cameron Kevin J C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 1 0 0 0 Common Stock 2018-06-30 4 A 0 10000 0 A 186666 D Stock Options (right to buy) 3.76 2018-06-30 4 A 0 30000 0 A 2019-06-30 2028-06-30 Common Stock 30000.0 30000 D The 10,000 shares are restricted common stock, with one-third of the 10,000 shares vesting on each of June 30, 2019, June 30, 2020 and June 30, 2021. Includes 19,999 shares of restricted stock. The 30,000 stock options vest as to one-third on each of June 30, 2019, June 30, 2020 and June 30, 2021. Scott A. Holmes, Attorney-in-Fact 2018-07-12